All News
STAT+: Does the FDA commissioner’s new voucher program open a Pandora’s box?
The FDA is setting up a pilot program to review some drugs within one to two months.
Read MoreOpinion: Thousands, including my husband, died because of tainted blood. I’m afraid it could happen again
Kathy Seward MacKay lost her husband in 1997 because of tainted blood-clotting products. She’s worried about history repeating itself.
Read MoreSTAT+: Psychedelics proponents hope Trump administration will foster a new era
HHS secretary Robert F. Kennedy Jr. declared that the FDA’s “suppression of psychedelics” was about to end.
Read MoreOpinion: STAT+: Deep Genomics founder: Why AI for drug discovery will far exceed current expectations
A pioneer in AI explains why he’s more enthusiastic than ever about AI for drug discovery.
Read MoreSuraksha Diagnostics, United Imaging Technologies collaborate to expand reach across East India
The collaboration involves a total investment of Rs 200 crore by Suraksha Diagnostics, and it aims to establish more than 20 new imaging centres across Eastern India
Read MoreMedtronic to invest $50 mn over 5 years in New Diabetes Global Capability Centre in Pune
The Diabetes GCC will be a centre of excellence that aims to enhance customer care, advanced analytics, and digital tech services, while also supporting patient financial services and operations
Read MoreA moment that changed me: I stepped into the boxing ring – and decades of quiet anger lifted
As I punched and shouted, I knew I didn’t have to be demure, delicate or diplomatic. I could be as fierce as I wanted.
Read MoreThe Last Mile in Prevention—Can Coronary CT Angiography Help?
We know how to prevent the majority of atherosclerotic cardiovascular disease (ASCVD), but this knowledge has not yet been translated into routine practice.
Read MoreCT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy
This cohort study investigates if coronary computed tomography (CT) angiography is associated with better lifestyle behaviors, acceptance of preventive therapies, and improvement in risk factor modifi
Read MoreFinerenone According to Frailty in Heart Failure
This prespecified secondary analysis of the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure (FINEARTS-HF) examines the efficacy and safety of fin
Read More